Delivery Order SPE2DR25D1053-SPE2DR26FT686
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with a ceiling value of $1,280.92 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs, with a ceiling value of $1,682.50 and an ultimate completion date of September 8, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Epidiolex 100 mg/ml solution in 60-milliliter packs, with a ceiling value of $1,280.92 and an ultimate completion date of July 24, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a $1,682.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Epidiolex 100 mg/ml solution in a 100 ml pack. This non-set-aside competitive award is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is a cannabidiol-based pharmaceutical used primarily for seizure management, reflecting the federal government's medical supply procurement...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs. The contract carries a firm fixed price ceiling value of $2,561.80 and is scheduled for completion by November 6, 2025. This delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $3,842.76. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a $2,523.75 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Epidiolex 100 mg/ml solution in 100ml packs. This is a firm fixed-price delivery order with a completion date of September 23, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT686Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $1,349.88 and an ultimate completion date of December 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Epidiolex, a cannabidiol-based medication indicated for seizure disorders, reflects the specialized pharmaceutical commodities within the scope of AmerisourceBergen Drug Corp's federal medical procurement portfolio. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, the company has demonstrated capability to meet federal procurement requirements across multiple therapeutic domains through open competition. This delivery order exemplifies the company's role in supporting Defense Health Agency medical supply needs through a flexible contracting vehicle designed to address evolving pharmaceutical requirements across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/6/25 |